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CRT Optimization
Don’t Forget the Atrium!*
Anne B. Curtis, MD,† Gustavo Lopera, MD‡
Buffalo, New York; and Miami, Floridat
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mClinical trials of cardiac resynchronization therapy
(CRT) have consistently demonstrated significant im-
provement in quality of life, functional status, and exer-
cise capacity in patients with heart failure (HF). CRT is
also associated with reverse left ventricular (LV) remod-
eling, improved systolic and diastolic function, and de-
creased mitral regurgitation. In addition, improvement in
survival was reported in the COMPANION (Compar-
ison of Medical Therapy, Pacing, and Defibrillation in
Heart Failure) and the CARE-HF (Cardiac Resynchro-
nization–Heart Failure) trials (1).
See page 691
Despite the positive outcomes observed with CRT in
HF, up to 30% of patients show no improvement with
CRT. Such failure to improve may be due to a lack of
baseline LV dyssynchrony, the presence of substantial
scar tissue, suboptimal LV lead position, and/or uncor-
rected dyssynchrony. This residual dyssynchrony can
occur at multiple levels: in the atria, between the atria and
the ventricles, or between the ventricles. Multiple meth-
odologies have been proposed to reduce cardiac dyssyn-
chrony and optimize CRT response through program-
ming of the atrioventricular (AV) and ventricle-ventricle
intervals, but no consensus has been reached on which
method is superior. Interestingly, the approach to AV
optimization varied widely in the CRT clinical trials,
with no AV optimization at all in the CONTAK CD
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reported that he has no relationships to disclose.rial, suggesting that even when imperfectly applied, a
ubstantial proportion of patients can derive clinical
enefit from CRT.
In this issue of iJACC, Liang et al. (2) elegantly
escribe the acute hemodynamic effects of atrial sens-
ng (AS) versus atrial pacing (AP) in CRT patients
nd find that AS is the optimal mode of programming
n CRT. We would like to emphasize 3 main findings
n this study. First, almost all Doppler-based measures
f ventricular hemodynamic performance, diastolic
lling time, and global strain were significantly better
n AS compared with AP mode. Second, in AS mode,
ctive atrial strain (atrial contractility) was significantly
igher, and all measurements of intra-atrial time
elays (mechanical synchrony) were significantly
horter. These findings indicate that the acute hemo-
ynamic benefits of AS are probably due to improved
trial contractility and synchrony and suggest that AP
ould lead to atrial dyssynchrony. Third, the optimal
V delay (AVD) observed with AP mode was 30
s longer than the optimal AVD with AS mode in
5% of the patients, indicating that a routine fixed
aced offset of 0 to 30 ms might be inadequate for the
ajority of CRT patients. Interestingly, Gold et al. (3)
ompared 3 noninvasive methods (Doppler based,
ntracardiac electrogram based, and fixed AVD) with
nvasive measurements of LV dP/dt to determine the
ptimal AVD during AS and AP modes in 28
atients undergoing CRT. The investigators found
hat the optimal AVD in AP mode was associated
ith a significantly greater increase in LV dP/dt
ompared with AS mode. They also found that the
ptimal AVD with the intracardiac electrogram based
ethod had better correlation with the maximum
chievable LV dP/dt compared with Doppler-based
r fixed AVD techniques. Similar to the study by
iang et al. (2), the optimal AVD observed with AP
ode was30 ms longer than the optimal AVD with
S mode in 88% of their patients, confirming that a
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700fixed paced offset of 0 to 30 ms might be inadequate
for the majority of CRT patients. The discrepancies in
the findings between the study by Gold et al. (3) and
he present study are difficult to explain, because both
tudies had adequate methodologies. Hence, further
linical studies are required to clearly establish the
ptimal method to assess hemodynamic improvement
n CRT patients.
Data on the deleterious effects of long-term AP
ave been overlooked in the clinical trials evaluating
acing therapy. These trials had mainly focused on the
ffects of ventricular dyssynchrony induced by right
entricular pacing. From these trials, we learned that
40% cumulative percent ventricular pacing is asso-
iated with a higher incidence of HF and atrial
brillation. These trials also showed that the adverse
utcomes of ventricular dyssynchrony induced by right
entricular pacing appear to be time dependent and
odulated by baseline LV systolic function, with an
arlier onset in patients with depressed LV systolic
unction. Moreover, these adverse clinical outcomes
ave been associated with concomitant atrial and
entricular remodeling (1). Hence, it is also possible
hat a high long-term cumulative percent AP could be
ssociated with further worsening in atrial function.
Programming AS mode in CRT patients may be
ifficult to achieve in those with concomitant sinus
ode dysfunction (SND) and/or chronotropic incom-
etence. Although the prevalence of SND in HF is
ot well known, SND is often observed in patients
ith HF. HF is associated with significant remodeling
f the sinus node, prolongation of corrected sinus
ode recovery times, and abnormal propagation of the
inus impulse. Moreover, SND could further be wors-
ned by medications with negative chronotropic ef-
ects, such as beta-blockers, amiodarone, and digoxin,
hich are commonly prescribed in patients with HF.
t present, it is not clear if lowering the lower rate
imit for pacing to 50 beats/min would result in higher
S rates and hence better hemodynamic status.
It is important to recognize that the optimal AVDs at
est and during exercise are different. Mokrani et al. (4)
ound that the optimal AVD on the basis of the LV
utflow tract velocity-time integral was shorter during
xercise than at rest in 37%, unchanged in 37%, and
onger in 26% of patients. Optimization of the AVD
uring exercise increased the LV outflow tract velocity-
ime integral significantly compared with any fixed
VD, optimal AVD at rest, and systematic shortening
f AVD during exercise (rate-adaptive AVD algorithm).
Clinical studies have demonstrated that fusion or
seudo-fusion decreases the long-term efficacy of
RT therapy. For this reason, the AS and AP AVDsre typically programmed short to avoid fusion and
seudo-fusion, because correction of LV dyssyn-
hrony requires that biventricular paced activation
eplace native ventricular activation. Hence, lengthen-
ng of the AP AVD to allow AS AVD in CRT
atients could create competition between continuous
iventricular pacing and native ventricular activation.
The results of the SMART-AV (Comparison of
V Optimization Methods Used in Cardiac Re-
ynchronization Therapy) trial add further com-
lexity to our understanding of CRT optimization.
n this trial, 980 CRT patients were prospectively
andomized to a fixed AVD, an echocardiographi-
ally optimized AVD, or an AVD optimized with
martDelay (an electrogram-based algorithm [Bos-
on Scientific Corporation, Natick, MA]). The
rimary end point was LV end-systolic volume.
econdary end points included New York Heart
ssociation functional class, quality-of-life score,
-min walking distance, LV end-diastolic volume,
nd LV ejection fraction. No differences in primary
r secondary end points were observed at 6 months.
The ideal sensed or paced AVD in CRT will probably
eed to be adjusted automatically and dynamically to
dapt to constant changes in hemodynamic conditions,
hich could be different for each patient. A recent study
uggested that the insertion of a sensor in the pacing lead
ould allow more dynamic and automatic adjustments of
he optimal AS or AP AVD (5).
In summary, programming to optimize the delivery
f CRT remains challenging. Future clinical trials
hould focus on the long-term clinical benefits of
emodynamic sensors embedded in pacing leads that
ill automatically and periodically change the AVD
sensed or paced) to better adjust to the constant
hanges in patients’ hemodynamic needs, which can
ary widely from time to time and from patient to
atient. Clinical trials that compare the results with
emodynamic sensors versus current echocardio-
raphy-based optimization techniques are desirable.
e also need clinical investigations into the benefits
f long-term AP versus AS. The latter are compli-
ated by practical issues of underlying sinus bradycar-
ia. Separating out the contributions of rate versus
ethod of atrial activation, sensed versus paced, will
e challenging. In any event, clinical outcomes are the
referred outcome measure, rather than simple echo-
ardiographic indexes of response. In programming
RT, we should remember: don’t forget the atrium!
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